Watchlist Price Alert

Cyclacel Pharmaceuticals ... (CYCCP)

NASDAQ: CYCCP · Real-Time Price · USD

4.05

-0.12 (-2.88%)

At close: May 08, 2025, 10:00 AM

Cyclacel Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-11.21M	-22.55M	-21.2M	-18.89M	-8.45M	-7.83M	-7.29M	-7.47M	-11.79M
Depreciation & Amortization	6K	31K	32K	43K	20K	20K	29K	32K	133K
Stock-Based Compensation	592K	1.47M	1.51M	1.16M	430K	466K	331K	266K	782K
Other Working Capital	4.43M	4.42M	-3.74M	-3.76M	31K	143K	-327K	1.23M	439K
Other Non-Cash Items	n/a	227K	-967K	-1.49M	347K	-38K	-165K	1.87M	782K
Deferred Income Tax	n/a	n/a	967K	1.49M	-347K	n/a	n/a	n/a	-794K
Change in Working Capital	2.62M	4.71M	-1.17M	-853K	61K	-2.06M	227K	-308K	809K
Operating Cash Flow	-7.99M	-16.11M	-20.83M	-18.54M	-7.93M	-9.45M	-6.7M	-7.48M	-10.08M
Capital Expenditures	n/a	-6K	-7K	-27K	-96K	-10K	-39K	-13K	-3K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	38K	n/a	n/a	12K
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	38K	n/a	n/a	12K
Investing Cash Flow	n/a	-6K	-7K	-27K	-96K	28K	-39K	-13K	9K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	-201K	-201K	-201K	-201K	-201K	-201K	-201K	-200K
Other Financial Acitivies	1.61M	n/a	n/a	4.57M	4.54M	4.05M	n/a	200K	n/a
Financial Cash Flow	7.82M	848K	3M	21.74M	29.5M	3.85M	429K	14.75M	6.59M
Net Cash Flow	-241K	-14.97M	-18.21M	3.15M	21.52M	-5.62M	-6.41M	7.39M	-3.92M
Free Cash Flow	-7.99M	-16.12M	-20.83M	-18.57M	-8.03M	-9.46M	-6.74M	-7.49M	-10.08M